Model NO.: 458-37-7
Assay: 99%
Trademark: YCGC
Transport Package: Foil Bag
Specification: 10g, 100g, 1kg, 5kg, 10kg
Origin: China
HS Code: 12345677
Model NO.: 458-37-7
Assay: 99%
Trademark: YCGC
Transport Package: Foil Bag
Specification: 10g, 100g, 1kg, 5kg, 10kg
Origin: China
HS Code: 12345677
Details of CurcuminProduct Name: | Curcumin |
Alias: | Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Turmeric yellow; Curcuma |
CAS: | 458-37-7 |
EINECS: | 207-280-5 |
MF: | C21H20O6 |
MW: | 368.38 |
Assay: | 99% |
Melting point: | 183ºC |
Water solubility: | Slightly soluble in water |
Density: | 0.93 |
Appearance: | Orange yellow crystalline powder |
Description of Curcumin
Curcumin is a yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.
Curcumin is a phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmcologic properties. Curcumin blocks the formation of reactive-oxygen species, possesses anti-inflammatory properties as a result of inhibition of cyclooxygenases (COX) and other enzymes involved in inflammation; and disrupts cell signal transduction by various mechanisms including inhibition of protein kinase C. These effects may play a role in the agent's observed antineoplastic properties, which include inhibition of tumor cell proliferation and suppression of chemically induced carcinogenesis and tumor growth in animal models of cancer. (NCI04).
Curcumin is a natural component of the rhizome of turmeric (Curcuma longa) and one of the most powerful chemopreventive and anticancer agents. Its biological effects range from antioxidant, anti-inflammatory to inhibition of angiogenesis and is also shown to possess specific antitumoral activity. The molecular mechanism of its varied cellular effects has been studied in some details and it has been shown to have multiple targets and interacting macromolecules within the cell. Curcumin has been shown to possess anti-angiogenic properties and the angioinhibitory effects of curcumin manifest due to down regulation of proangiogenic genes such as VEGF and angiopoitin and a decrease in migration and invasion of endothelial cells. One of the important factors implicated in chemoresistance and induced chemosensitivity is NFkB and curcumin has been shown to down regulate NFkB and inhibit IKB kinase thereby suppressing proliferation and inducing apoptosis. Cell lines that are resistant to certain apoptotic inducers and radiation become susceptible to apoptosis when treated in conjunction with curcumin. Besides this it can also act as a chemopreventive agent in cancers of colon, stomach and skin by suppressing colonic aberrant crypt foci formation and DNA adduct formation. This review focuses on the various aspects of curcumin as a potential drug for cancer treatment and its implications in a variety of biological and cellular processes vis-à -vis its mechanism of action (PMID: 16712454). Turmeric (Zingiberaceae family) rhizomes, has been widely used for centuries in indigenous medicine for the treatment of a variety of inflammatory conditions and other diseases. Its medicinal properties have been attributed mainly to the curcuminoids and the main component present in the rhizome is curcumin. Curcumin has been shown to possess wide range of pharmacological activities including anti-inflammatory, anti-cancer, anti-oxidant, wound healing and anti-microbial effects. Recently, curcumin treatment has been shown to correct defects associated with cystic fibrosis in homozygous DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) knock out mice. In vivo and in vitro studies have demonstrated curcumin's ability to inhibit carcinogenesis at three stages: tumor promotion, angiogenesis and tumor growth. Curcumin suppresses mitogen-induced proliferation of blood mononuclear cells, inhibits neutrophil activation and mixed lymphocyte reaction and also inhibits both serum-induced and platelet derived growth factor (PDGF)-dependent mitogenesis of smooth muscle cells. It has also been reported to be a partial inhibitor of protein kinase. The other salient feature of turmeric/curcumin is that despite being consumed daily for centuries in Asian countries, it has not been shown to cause any toxicity (PMID: 16413584).
Usage of Curcumin
Curcumin is a natural phenolic compound.Â
Curcumin is a potent anti-tumor agent having anti-inflammatory and anti-oxidant properties.
Curcumin can induces apoptosis in cancer cells and inhibits phorbol ester-induced protein kinase C (PKC) activity.Â
Reported to that Curcumin can inhibit production of inflammatory cytokines by peripheral blood monocytes and alveolar macrophages.Â
Curcumin is a potent inhibitor of EGFR tyrosine kinase and IκB kinase. Curcumin can inhibits inducible nitric oxide synthase (iNOS), cycloxygenase and lipoxygenase.Â
Curcumin easily penetrates into the cytoplasm of cells, accumulating in membranous structures such as plasma membrane, endoplasmic reticulum and nuclear envelope.Â
Quality Specification of Curcumin
Items  | Specifications | Results | Method | |
Chemical Test             compacted density | ||||
Identification | Positive by HPLC | |||
By IR spectrum | The IR spectrum of sample is concordant with that of standard | |||
Solubility | Slightly soluble in alcohol, soluble in acetone and in glacial acetic acid | Complies | Note | |
Assay | Total Curcuminoids ≥95.0% | 95.1% | HPLC | |
E;1 (425nm) |  ≥ 1450 | 1520 | UV | |
Loss on Drying | ≤ 2.0% | 0.6% | CP2010 | |
Ash | ≤ 1.0 % | 0.2% | CP2010 | |
Compacted density | 0.5-0.9 g/ml | 0.63 g/ml | CP2010 | |
Loose Bulk Density | 0.3-0.5 g/ml | 0.42g/ml | CP2010 | |
Heavy Metals | ≤ 10 ppm | Complies | GB/T5009.74-2003 | |
Arsenic   (As) | ≤ 2 ppm | <0.3 ppm | GB/T5009.11-2003 | |
Lead     (Pb) | ≤ 2 ppm | < 0.3ppm | GB/T5009.12-2010 | |
Cadmium(Cd) |  ≤1ppm |  0.2 | GB/T5009.15-2003 | |
Mercury  (Hg) |  ≤0.5ppm |  0.2 | GB/T5009.17-2003 | |
Solvent Residue | -- | Complies | FDA | |
Microbial Analysis | ||||
Total Plate Count | < 10000 cfu/g | 3000 | GB4789.2-2010 | |
Yeast and Mold | < 100 cfu/g | 50 | GB4789.15-2003 | |
Escherichia Coli | Negative | Not Detected | GB4789.3-2010 |
Our advantage
a.Rich experience.We are a professional manufacturer in China for many years,our products have exported to Germany,Spain,UK,USA,Australia,Middle East and so many other countries,and we have got very good feedback from our customers,we had Established many long friendly relations of cooperation.
b.Great quality,purity and competitive price.Different country with different and suitable way of packing.Packing pictures will be sent to you as soon as possible after your payment.
c.Safe and fast delivery.We will send you with a safest and most suitable channel.
d.Good after-sales service.Our purpose is to hold a long friendly cooperation with our customers,so we will offer you best service from start to finish.
 Details of Curcumin
Product Name: | Curcumin |
Alias: | Curcumin; 458-37-7; Diferuloylmethane; Natural yellow 3; Turmeric yellow; Curcuma |
CAS: | 458-37-7 |
EINECS: | 207-280-5 |
MF: | C21H20O6 |
MW: | 368.38 |
Assay: | 99% |
Melting point: | 183ºC |
Water solubility: | Slightly soluble in water |
Density: | 0.93 |
Appearance: | Orange yellow crystalline powder |
Description of Curcumin
Curcumin is a yellow-orange dye obtained from tumeric, the powdered root of CURCUMA longa. It is used in the preparation of curcuma paper and the detection of boron. Curcumin appears to possess a spectrum of pharmacological properties, due primarily to its inhibitory effects on metabolic enzymes.
Curcumin is a phytopolylphenol pigment isolated from the plant Curcuma longa, commonly known as turmeric, with a variety of pharmcologic properties. Curcumin blocks the formation of reactive-oxygen species, possesses anti-inflammatory properties as a result of inhibition of cyclooxygenases (COX) and other enzymes involved in inflammation; and disrupts cell signal transduction by various mechanisms including inhibition of protein kinase C. These effects may play a role in the agent's observed antineoplastic properties, which include inhibition of tumor cell proliferation and suppression of chemically induced carcinogenesis and tumor growth in animal models of cancer. (NCI04).
Curcumin is a natural component of the rhizome of turmeric (Curcuma longa) and one of the most powerful chemopreventive and anticancer agents. Its biological effects range from antioxidant, anti-inflammatory to inhibition of angiogenesis and is also shown to possess specific antitumoral activity. The molecular mechanism of its varied cellular effects has been studied in some details and it has been shown to have multiple targets and interacting macromolecules within the cell. Curcumin has been shown to possess anti-angiogenic properties and the angioinhibitory effects of curcumin manifest due to down regulation of proangiogenic genes such as VEGF and angiopoitin and a decrease in migration and invasion of endothelial cells. One of the important factors implicated in chemoresistance and induced chemosensitivity is NFkB and curcumin has been shown to down regulate NFkB and inhibit IKB kinase thereby suppressing proliferation and inducing apoptosis. Cell lines that are resistant to certain apoptotic inducers and radiation become susceptible to apoptosis when treated in conjunction with curcumin. Besides this it can also act as a chemopreventive agent in cancers of colon, stomach and skin by suppressing colonic aberrant crypt foci formation and DNA adduct formation. This review focuses on the various aspects of curcumin as a potential drug for cancer treatment and its implications in a variety of biological and cellular processes vis-à -vis its mechanism of action (PMID: 16712454). Turmeric (Zingiberaceae family) rhizomes, has been widely used for centuries in indigenous medicine for the treatment of a variety of inflammatory conditions and other diseases. Its medicinal properties have been attributed mainly to the curcuminoids and the main component present in the rhizome is curcumin. Curcumin has been shown to possess wide range of pharmacological activities including anti-inflammatory, anti-cancer, anti-oxidant, wound healing and anti-microbial effects. Recently, curcumin treatment has been shown to correct defects associated with cystic fibrosis in homozygous DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) knock out mice. In vivo and in vitro studies have demonstrated curcumin's ability to inhibit carcinogenesis at three stages: tumor promotion, angiogenesis and tumor growth. Curcumin suppresses mitogen-induced proliferation of blood mononuclear cells, inhibits neutrophil activation and mixed lymphocyte reaction and also inhibits both serum-induced and platelet derived growth factor (PDGF)-dependent mitogenesis of smooth muscle cells. It has also been reported to be a partial inhibitor of protein kinase. The other salient feature of turmeric/curcumin is that despite being consumed daily for centuries in Asian countries, it has not been shown to cause any toxicity (PMID: 16413584).
Usage of Curcumin
Curcumin is a natural phenolic compound.Â
Curcumin is a potent anti-tumor agent having anti-inflammatory and anti-oxidant properties.
Curcumin can induces apoptosis in cancer cells and inhibits phorbol ester-induced protein kinase C (PKC) activity.Â
Reported to that Curcumin can inhibit production of inflammatory cytokines by peripheral blood monocytes and alveolar macrophages.Â
Curcumin is a potent inhibitor of EGFR tyrosine kinase and IκB kinase. Curcumin can inhibits inducible nitric oxide synthase (iNOS), cycloxygenase and lipoxygenase.Â
Curcumin easily penetrates into the cytoplasm of cells, accumulating in membranous structures such as plasma membrane, endoplasmic reticulum and nuclear envelope.Â
Quality Specification of Curcumin
Items  | Specifications | Results | Method | |
Chemical Test             compacted density | ||||
Identification | Positive by HPLC | |||
By IR spectrum | The IR spectrum of sample is concordant with that of standard | |||
Solubility | Slightly soluble in alcohol, soluble in acetone and in glacial acetic acid | Complies | Note | |
Assay | Total Curcuminoids ≥95.0% | 95.1% | HPLC | |
E;1 (425nm) |  ≥ 1450 | 1520 | UV | |
Loss on Drying | ≤ 2.0% | 0.6% | CP2010 | |
Ash | ≤ 1.0 % | 0.2% | CP2010 | |
Compacted density | 0.5-0.9 g/ml | 0.63 g/ml | CP2010 | |
Loose Bulk Density | 0.3-0.5 g/ml | 0.42g/ml | CP2010 | |
Heavy Metals | ≤ 10 ppm | Complies | GB/T5009.74-2003 | |
Arsenic   (As) | ≤ 2 ppm | <0.3 ppm | GB/T5009.11-2003 | |
Lead     (Pb) | ≤ 2 ppm | < 0.3ppm | GB/T5009.12-2010 | |
Cadmium(Cd) |  ≤1ppm |  0.2 | GB/T5009.15-2003 | |
Mercury  (Hg) |  ≤0.5ppm |  0.2 | GB/T5009.17-2003 | |
Solvent Residue | -- | Complies | FDA | |
Microbial Analysis | ||||
Total Plate Count | < 10000 cfu/g | 3000 | GB4789.2-2010 | |
Yeast and Mold | < 100 cfu/g | 50 | GB4789.15-2003 | |
Escherichia Coli | Negative | Not Detected | GB4789.3-2010 |
Our advantage
a.Rich experience.We are a professional manufacturer in China for many years,our products have exported to Germany,Spain,UK,USA,Australia,Middle East and so many other countries,and we have got very good feedback from our customers,we had Established many long friendly relations of cooperation.
b.Great quality,purity and competitive price.Different country with different and suitable way of packing.Packing pictures will be sent to you as soon as possible after your payment.
c.Safe and fast delivery.We will send you with a safest and most suitable channel.
d.Good after-sales service.Our purpose is to hold a long friendly cooperation with our customers,so we will offer you best service from start to finish.
Â
Conventional Fire Blanket,Welding Fire Blanket,Anti Fireblanket,Fiberglass Fire Blanket
Huaian Wuzhou E-Commerce Co.,Ltd , https://www.tescoequipment.com